MARKET

NDRAW

NDRAW

ENDRA LIFE SCNCS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.1500
+0.0196
+14.99%
Closed 16:00 12/03 EST
OPEN
0.1400
PREV CLOSE
0.1304
HIGH
0.1500
LOW
0.1002
VOLUME
1.34K
TURNOVER
--
52 WEEK HIGH
0.6000
52 WEEK LOW
0.0601
MARKET CAP
--
P/E (TTM)
-0.0830
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
No Data
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NDRAW. Analyze the recent business situations of ENDRA LIFE SCNCS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.41%
Pharmaceuticals & Medical Research
+0.49%
Key Executives
Chairman/Chief Executive Officer/Director
Francois Michelon
Chief Financial Officer
David Wells
Chief Technology Officer
Michael Thornton
Other
Renaud Maloberti
Independent Director
Louis Basenese
Independent Director
Anthony DiGiandomenico
Independent Director
Sanjiv Gambhir
Independent Director
Michael Harsh
Independent Director
Alexander Tokman
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NDRAW
ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of ENDRA Life Sciences Inc stock information, including NASDAQ:NDRAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NDRAW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NDRAW stock methods without spending real money on the virtual paper trading platform.